Gianluca Sbardella

Biomolecular and biophysical approaches to interrogate p300: a platform for drug discovery.

Alessandra Feoli, Ciro Milite, Alessandra Tosco, 2015 .

Dynamical Aspects of TEM-1 β-Lactamase Probed by Molecular Dynamics

Massimiliano Aschi, Cecilia Bossa, Alfredo Di Nola, 2005, J. Comput. Aided Mol. Des..

Un elemento di valutazione della qualità della didattica universitaria = An element of evaluation of the quality of university teaching

Andrea Pelissetto, Gianluca Sbardella, Francesco Sebastianelli, 2016, Roars Trans..

Identification of new KDM4 inhibitors through a HTS and hit refinement strategy

Ciro Milite, Sabrina Castellano, Gianluca Sbardella, 2017 .

Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.

Barbara Costa, Ettore Novellino, Luciana Marinelli, 2014, Journal of medicinal chemistry.

Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.

Silvio Massa, Rino Ragno, Gianluca Sbardella, 2004, Journal of medicinal chemistry.

Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation.

Silvio Massa, Rino Ragno, Gianluca Sbardella, 2002, Journal of medicinal chemistry.

Dynamical aspects of TEM-1 beta-lactamase probed by molecular dynamics.

Massimiliano Aschi, Cecilia Bossa, Gianluca Sbardella, 2005, Journal of computer-aided molecular design.

Slow‐, Tight‐Binding HIV‐1 Reverse Transcriptase Non‐Nucleoside Inhibitors Highly Active against Drug‐Resistant Mutants

Gianluca Sbardella, Antonello Mai, Imma Clotet-Codina, 2007, ChemMedChem.